Abstract
Since 1981 we have cultured and prepared lipophilic and hydrophilic extracts from more than 1500 strains representing some 400 species of blue-green algae. Screening for a wide variety of potentially useful bioactivities, including cytotoxic, multi-drug-resistance reversal, antifungal, and antiviral effects, has led to the discovery and identification of numerous novel bioactive metabolites including peptides, macrolides and glycosides.
A systematic evaluation of the chemical and environmental factors that influence the production of secondary metabolites inScytonema ocellatum, which produces tolytoxin (a macrocyclic lactone that depolymerizes actinin vivo to disrupt cell division in eukaryotic organisms), has shown that cyanophytes can be manipulated in culture to improve growth and product yields.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Behrens PW, Sicotte VJ, Delente J (1994) Microalgae as a source of stable isotopically labeled compounds. J. appl. Phycol. 6: 113–121.
Benemann JR, Tillett DM, Weissman JC (1987) Microalgae biotechnology. Trends Biotechnol. 5: 47–53.
Bonjouklian R, Smitka TA, Doolin LE, Molloy RM, Debono M, Shaffer SA, Moore RE, Stewart JB, Patterson GML (1991) Tjipanazoles, new antifungal agents from the blue-green algaTolypothrix tjipanasensis. Tetrahedron 47: 7739–7750.
Carmeli S, Moore RE, Patterson GML (1990a) Tolytoxin and new scytophycins from three species ofScytonema. J. nat. Prod. 53: 1533–1542.
Carmeli S, Moore RE, Patterson GML, Mori Y, Suzuki M (1990b) Isonitriles from the blue-green algaScytonema mirabile. J. org. Chem. 55: 4431–4438.
Carmeli S, Moore RE, Patterson GML, Corbett TH, Valeriote FA (1990c) Tantazoles, unusual cytotoxic alkaloids from the blue-green algaScytonema mirabile. J. am. chem. Soc. 112: 8195–8197.
Carmeli S, Moore RE, Patterson GML (1991a) Mirabimides A-D, new N-Acylpyrrolinones from the blue-green algaScytonema mirabile. Tetrahedron 47: 2087–2096.
Carmeli S, Moore RE, Patterson GML (1991b) Mirabazoles, minor tantazole-related cytotoxins from the terrestrial blue-green algaScytonema mirabile. Tetrahedron Lett. 32: 2593–2596.
Carmeli S, Paik S, Moore RE, Patterson GML, Yoshida WY (1993) Revised structures and biosynthetic studies of tantazoles A and B. Tetrahedron Lett 34: 6681–6684.
Frankmölle WP, Larsen LK, Caplan FR, Patterson GML, Knübel G, Levine IA, Moore RE (1992a) Antifungal cyclic peptides from the terrestrial blue-green algaAnabaena laxa. I. Isolation and biological properties. J. Antibiot. 45: 1451–1457.
Frankmölle WP, Knübel G, Moore RE, Patterson GML (1992b) Antifungal cyclic peptides from the terrestial blue-green algaAnabaena laxa. II. Structures of laxaphycins A, B, D, and E. J. Antibiot. 45: 1458–1466.
Gerwick WH, Mrozek C, Moghaddam MF, Agarwal SK (1989) Novel cytotoxic peptides from the tropical marine cyanobacteriumHormothamnion enteromorphoides. 1. Discovery, isolation, and initial chemical and biological characterization of the hormothamnins from wild and cultured material. Experientia 45: 115–121.
Gibbons A (1993) Where are ‘new’ diseases born? Science 261: 680–681.
Gustafson KR, Cardellina II JH, Fuller RW, Weislow OS, Kiser RF, Snader KM, Patterson GML, Boyd MR (1989) AIDS-Antiviral sulfolipids from cyanobacteria (blue green algae). J. nat. cancer Inst. 81: 1254–1258.
Hambley TW, Hawkins CJ, Lavin MF, van der Brenk A, Watters DJ (1992) Cycloxasoline — a cytotoxic cyclic hexapeptide from the ascidianLissoclinum bistratum. Tetrahedron 48: 341–348.
Ishibashi M, Moore RE, Patterson GML, Xu C, Clardy J (1986) Scytophycins, cytotoxic and antimycotic agents from the cyanophyteScytonema pseudohofmanni. J. org. Chem. 51: 5300–5306.
Jung JH, Moore RE, Patterson GML (1991) Scytophycins from a blue-green alga belonging to the nostocaceae. Phytochemistry 30: 3615–3616.
Knübel G, Larsen LK, Moore RE, Levine IA, Patterson GML (1990) Cytotoxic, antiviral indolocarbazoles from a blue-green alga belonging to the nostocaceae. J. Antibiot. 43: 1236–1239.
Lau AF, Siedlecki J, Anleiter J, Patterson GML, Caplan FR, Moore RE (1993) Inhibition of reverse transcriptase activity by extracts of cultured blue-green algae (Cyanophyta). Planta Med. 59: 148–151.
Moore RE (1981) Constituents of blue-green algae. In Scheuer PJ (ed.), Marine Natural Products: Chemical and Biological Perspectives, Vol. 4. Academic Press, New York: 1–52.
Moore RE, Patterson GML, Carmichael WW (1988) New pharmaceuticals from cultured blue-green algae. Mem. Cal. Acad. Sci. 13: 143–150.
Ōmura S (1992) The Search for Bioactive Compounds from Microorganisms. Springer-Verlag, New York, 352 pp.
Patterson GML, Bolis CM (1993) Regulation of scytophycin accumulation in batch cultures ofScytonema ocellatum. I. Physical factors. Appl. Microbiol. Biotechnol. 39: In press.
Patterson GML, Carmeli S (1992) Biological effects of tolytoxin (6-hydroxy-7-O-methyl-scytophycin B), a potent bioactive metabolite from cyanobacteria. Arch. Microbiol. 157: 406–410.
Patterson GML, Baldwin CL, Bolis CM, Caplan FR, Karuso H, Larsen LK, Levine IA, Moore RE, Nelson CS, Tuang GD, Furusawa E, Furusawa S, Norton TR, Raybourne RR (1991) Antineoplastic activity of cultured blue-green algae (cyanobacteria). J. Phycol. 27: 530–536.
Patterson GML, Baker KK, Baldwin CL, Bolis CM, Caplan FR, Larsen LK, Levine IA, Moore RE, Nelson CS, Tschappat KD, Tuang GD, Boyd MR, Cardellina II JH, Collins RP, Gustafson KR, Snader KM, Weislow OR (1993a) Antiviral activity of cultured blue-green algae (Cyanophyta). J. Phycol. 29: 125–130.
Patterson GML, Smith CD, Kimura LH, Britton BA, Carmeli S (1993b) Action of tolytoxin on cell morphology, cytoskeletal organization, and actin polymerization. Cell Motility Cytoskeleton 24: 39–48.
Prinsep MR, Moore RE, Levine IA, Patterson GML (1992a) Westiellamide, a bistratamide-related cyclic peptide from the blue-green algaeWestiellopsis prolifica. J. nat. Prod. 55: 140–142.
Prinsep MR, Caplan FR, Moore RE, Patterson GML, Smith CD (1992b) Tolyporphin, a novel multidrug reversing agent from the blue-green algaTolypothrix nodosa. J. am. chem. Soc. 114: 385–387.
Rinehart Jr KL, Shaw PD, Shield LS, Gloer JB, Harbour GC, Koker MES, Samain D, Schwartz RE, Tymiak AA, Weller DL, Carter GT, Munro MHG, Hughes Jr RG, Renis HE, Swynenberg EB, Stringfellow DA, Vavra JJ, Coats JH, Zurenko GE, Kuentzel SL, Li LH, Bakus GJ, Brusca RC, Craft LL, Young DN, Connor JL (1981) Marine natural products as sources of antiviral, antimicrobial, and antineoplastic agents. Pure appl. Chem. 53: 795–817.
Shimizu Y (1993) Dinoflagellates as sources of bioactive molecules. In Attaway DH, Zaborsky OR (eds), Marine Biotechnology, Volume I: Pharmaceutical and Bioactive Natural Products. Plenum Press, New York: 391–410.
Suffness M, Pezzuto JM (1991) Assays related to cancer drug discovery. In Hostettmann K (ed.), Methods in Plant Biochemistry, Vol. 6. Academic Press, London: 71–133.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Patterson, G.M.L., Larsen, L.K. & Moore, R.E. Bioactive natural products from blue-green algae. J Appl Phycol 6, 151–157 (1994). https://doi.org/10.1007/BF02186069
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02186069